Depressive Disorders - NAFTA | Statista Market Forecast

Revenue in the Depressive Disorders market is projected to reach US$7.89bn in 2024.
Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 0.76%, resulting in a market volume of US$8.20bn by 2029.
In global comparison, most revenue will be generated United States (US$6.26bn in 2024).
In relation to total population figures, per person revenues of US$292.10 are generated in 2024.

Depressive disorders are a common type of mental illness. Symptoms include depressive moods such as feeling sad, low concentration, low self-worth, loss of interest in activities, and, in some cases, thoughts of suicide. Common treatments for depressive disorders include psychological treatments such as psychotherapy, behavioral therapy, and antidepressant medication.

The Depressive Disorders market in the Mental Health market represents the market for antidepressant drug sales. Different types of antidepressants are usually prescribed for the treatment of mild to serious cases of depression, e.g., selective serotonin reuptake inhibitors (SSRIs), serotonin norepinephrine reuptake inhibitor (SNRIs), serotonin modulators, as well as tricyclic and tetracyclic antidepressants.

Market values represent the revenues generated by manufacturers and are based on retail prices for each drug category including all drugs, regardless of whether they are reimbursed or not.

Company examples: Novartis AG, Pfizer, Bristol-Myers Squibb, GlaxoSmithKline, Patheon Inc, and Sandoz Inc.

Antidepressant drugs
Selective serotonin reuptake inhibitors (SSRIs)
Serotonin norepinephrine reuptake inhibitor (SNRIs)
Serotonin modulators
Tricyclic and tetracyclic antidepressants

Psychotherapy
Mood stabilizers
Anti-anxiety and stimulant medications
Behavioral therapy

The Depressive Disorders market in NAFTA is experiencing significant growth and development due to several key factors.

Customer preferences: Customers in the NAFTA region have shown a growing preference for seeking treatment for depressive disorders. This can be attributed to increasing awareness and understanding of mental health issues, as well as reduced stigma surrounding these conditions. Additionally, the availability of a wide range of treatment options, including therapy, medication, and alternative therapies, has also contributed to the growing demand for depressive disorder treatments.

Trends in the market: One of the key trends in the Depressive Disorders market in NAFTA is the increasing use of digital platforms for mental health support and treatment. Online therapy sessions and mental health apps have gained popularity, allowing individuals to access help and support from the comfort of their own homes. This trend has been accelerated by the COVID-19 pandemic, which has limited in-person interactions and increased the need for remote mental health services.Another trend in the market is the growing focus on personalized treatment plans. Healthcare providers are recognizing that depressive disorders can vary significantly from person to person, and that a one-size-fits-all approach may not be effective. As a result, there is a shift towards tailoring treatment plans to individual needs, taking into account factors such as the severity of symptoms, underlying causes, and patient preferences.

Local special circumstances: In the United States, the largest market within NAFTA, the high prevalence of depressive disorders has been a driving force behind market growth. The country has seen a steady increase in the number of individuals seeking treatment for depression, leading to a greater demand for depressive disorder treatments. Additionally, the availability of insurance coverage for mental health services has made treatment more accessible to a larger portion of the population.In Canada, the second largest market within NAFTA, the government has made efforts to improve access to mental health services. This has included increased funding for mental health programs and initiatives, as well as the implementation of telemedicine services in remote areas. These efforts have contributed to the growth of the Depressive Disorders market in Canada.

Underlying macroeconomic factors: The overall economic growth in the NAFTA region has also played a role in the development of the Depressive Disorders market. As economies have expanded, individuals have had more disposable income to spend on healthcare, including mental health treatments. Additionally, the aging population in the region has contributed to the growth of the market, as older individuals are more likely to experience depressive disorders and seek treatment.In conclusion, the Depressive Disorders market in NAFTA is experiencing growth and development due to increasing customer preferences for treatment, the adoption of digital platforms and personalized treatment plans, local special circumstances such as prevalence and government initiatives, and underlying macroeconomic factors such as economic growth and an aging population. These factors are likely to continue driving the growth of the market in the coming years.

Data coverage:

Data encompasses B2C enterprises. Figures are based on companies' revenues, international institutes data, and global consumer survey data. Revenues refer to the retail value and include sales taxes.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use financial reports and third-party data. Next, we use relevant key market indicators and data from country-specific associations such as healthcare spending per capita, medical product spending per capita, and gross domestic product per capita. This data helps us to estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, S-Curve function, ARIMA time series model and exponential curve function. Data is modeled using current exchange rates.

Additional Notes:

The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. GCS data is reweighted for representativeness.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

Despite what some may think, mental health problems are common in the United States and around the world. Mental health issues, much like other health issues, can be mild, but can also be life altering, affecting the emotional, social, and psychological well-being of the person. Common types of mental illness include mood disorders, anxiety disorders, eating disorders, and personality disorders. Although symptoms of mental illness differ depending on the type of illness and seriousness of the problem, common symptoms of mental health issues include changes in sleeping and eating habits, social withdrawal, feelings of hopelessness, anger, and prolonged sadness, suicidal thoughts, and substance abuse. In 2022, it was estimated that around 36 percent of those in the U.S. aged 18 to 25 years and 29 percent of those aged 26 to 49 years suffered from some form of mental illness in the past year.